0001179110-21-008515.txt : 20210901
0001179110-21-008515.hdr.sgml : 20210901
20210901201245
ACCESSION NUMBER: 0001179110-21-008515
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210831
FILED AS OF DATE: 20210901
DATE AS OF CHANGE: 20210901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Appelhans Dannielle
CENTRAL INDEX KEY: 0001874962
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 211231478
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS, INC.
STREET 2: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2021-08-31
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001874962
Appelhans Dannielle
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY ST., SUITE 300
CAMBRIDGE
MA
02139
0
1
0
0
Chief Operating Officer
Stock Option (Right to Buy)
21.72
2021-08-31
4
A
0
150000
0
A
2031-08-30
Common Stock
150000
150000
D
Restricted Stock Units
2021-08-31
4
A
0
50000
0
A
Common Stock
50000
50000
D
25% of this option shall vest on August 9, 2022, then in 12 equal quarterly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The shares underlying the restricted stock units will vest in four equal annual installments beginning on August 9, 2022.
/s/ Joanne M. Protano, Attorney-in-Fact
2021-09-01